New ‘supermolecule’ seeks and removes harmful pharmaceuticals from water
April 13, 2017Research and Development university of surrey
Researchers at the University of Surrey have discovered a ‘supermolecule’ which they claim can seek harmful pharmaceuticals from water in …
Love it or hate it – Vitamin B12 may give the brain a boost
April 13, 2017Research and Development Marmite, anxiety, epilepsy
Trying to explain to someone outside of the UK or Australia and New Zealand what Marmite is can be a …
UK heading towards GP crisis as 40% consider leaving
April 12, 2017Medical Communications, Research and Development GPs, General Practice, Jeremy Hunt, NHS
The University of Exeter has conducted a survey looking into GP morale in the south-west of the UK, and the …
Discovery of predictive protein signature births new leukaemia treatment hopes
April 12, 2017Research and Development leukaemia
Researchers have discovered a protein signature which has proven to be highly predictive of leukaemia and has given rise to …
FDA approves first and only tardive dyskinesia treatment
April 12, 2017Research and Development, Sales and Marketing FDA, Neurocrine Biosciences, tardive dyskinesia
US patients suffering with tardive dyskinesia (TD) will see access to the first approved treatment in the country with the …
Komodo dragon blood could hold secret to new antibiotic
April 12, 2017Research and Development Antibiotics, Komodo dragon, antibiotic resistance
The urgency to find new antibiotics has led researchers into the mouths of Komodo dragons. In particular, the researchers were …
Huge doses of vitamin C found to boost cancer treatment
April 12, 2017Research and Development Cancer, Vitamin c
It may sound like the kind of science that would raise eyebrows rather than scientific interest but recent research has …
e-Therapeutics installs new CEO in position
April 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing e-Therapeutics
e-Therapeutics, a drug discovery company, announced that Dr. Raymond Barlow assumed the position of CEO at the beginning of April. …
Trials and Tribulations: The impact of new clinical trial regulation in Europe
April 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, clinical trials, regulations
The clinical trial is the fulcrum on which drug development and treatment hinges. Even with the advent of new technologies …
Hilleman labs partners with Indian Government for shigella vaccine
April 11, 2017Manufacturing and Production, Sales and Marketing NICED, hilleman, shigella
India’s Hilleman Laboratories and the National Institute of Cholera and Enteric Diseases (NICED) are set to develop and market a …
J&J acquires Neuravi to bolster neuro business
April 11, 2017Manufacturing and Production, Sales and Marketing Johnson & Johnson, Neuravi
Johnson & Johnson’s neurosurgery and neurovascular unit, Codman Neuro, has made the move to acquire Galway-based company, Neuravi. The exact …
Scotland recommends Janssen’s Imbruvica for leukaemia
April 11, 2017Manufacturing and Production, Sales and Marketing SMC, imbruvica, leukaemia
Janssen has been celebrating the news that its Imbruvica (ibrutinib) has been recommended by the Scottish Medicines Consortium (SMC) for …
Egypt and India ties in pharmaceuticals encouraged
April 11, 2017Manufacturing and Production Egypt, India, Sun Pharma
India and Egypt have been tentatively trying to build economic links for the last few years, with a particular focus …
NICE turns down BMS’ Opdivo for head and neck cancer
April 11, 2017Manufacturing and Production, Sales and Marketing BMS, NICE, opdivo
Bad news for Bristol-Myers Squibb as NICE chooses not to recommend its immunotherapy drug Opdivo (nivolumab) for use in head …
Bioverativ installs new EVP of R&D
April 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bioverativ
Bioverativ, a biotech company that develops therapies for rare blood disorders, announced the appointment of Tim Harris as Executive Vice …
FDA approves first two antiviral hep C drugs for paediatric patients
April 10, 2017Sales and Marketing FDA, harvoni, hepatitis C, sovaldi
The FDA has given the go-ahead for two hepatitis C treatments for use in young and adolescent patients: Sovaldi (sofosbuvir) …
Virus fixes DNA mutations for possible hearing loss therapy
April 10, 2017Research and Development, Sales and Marketing Ear, deafblindness, hearing loss, inner hair
Researchers at the Medical School at Harvard and MedUni Vienna’s Department of Ear, Nose and Throat Diseases have managed to …
EMA green lights Actelion’s drug after patient deaths scare
April 10, 2017Sales and Marketing Actelion, Johnson & Johnson, Uptravi
The EMA has ruled that the five patient deaths that occurred in February of this year were not directly related …
Roche’s lung cancer drug beats Pfizer rival in study
April 10, 2017Research and Development, Sales and Marketing Alecensa, Roche
Roche has announced that its drug Alecensa (alectinib) succeeded in meeting its primary endpoint in a Phase 3 trial assessing …
Fresenius confirms takeover talks with Akorn
April 10, 2017Sales and Marketing Akorn, Fresenius
Fresenius, Europe’s largest publicly traded healthcare provider, has engaged in discussions with Akorn, a pharmaceutical generics drugmaker, with a view …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
